CoChat

The DOI matches its Crossref record; 138 of the 141 references it cites were found in a registry or an index; none of the 97 sources its claims cite is checked for support yet.

The emerging role of glucagon-like peptide 1 in binge eating

Open access
Balantekin, Katherine N, Kretz, Martin J, Mietlicki-Baase, Elizabeth G · 2024 · Journal of Endocrinology

Abstract

Binge eating is a central component of two clinical eating disorders: binge eating disorder and bulimia nervosa. However, the large treatment gap highlights the need to identify other strategies to decrease binge eating. Novel pharmacotherapies may be one such approach. Glucagon-like peptide-1 (GLP-1) is an intestinal and brain-derived neuroendocrine signal with a critical role in promoting glycemic control through its incretin effect. Additionally, the energy balance effects of GLP-1 are well-established; activation of the GLP-1 receptor (GLP-1R) reduces food intake and body weight. Aligned with these beneficial metabolic effects, there are GLP-1R agonists that are currently used for the treatment of diabetes and obesity. A growing body of literature suggests that GLP-1 may also play an important role in binge eating. Dysregulation of the endogenous GLP-1 system is associated with binge eating in non-human animal models, and GLP-1R agonists may be a promising approach to suppress the overconsumption that occurs during binge eating. Here, we briefly discuss the role of GLP-1 in normal energy intake and reward and then review the emerging evidence suggesting that disruptions to GLP-1 signaling are associated with binge eating. We also consider the potential utility of GLP-1-based pharmacotherapies for reducing binge eating behavior.

Overview

Integrity signals

Registry

Crossref · 10.1530/joe-23-0405

Cites

138 of 138 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 Valid · 0 Not valid · 81 Not checked · 20 Own results and interpretations

69 more claims

Create a free account to see all 101 claims and to verify the 97 references still open.

See all claims — free account
  • Probably not a substantial claim. 7
  • It may state two separate claims as one. 19
  • The quote only partly states this claim. 3

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 138 references

Cited by

See all 51

Metadata

Authors
Balantekin, K. N., Kretz, M. J., & Mietlicki-Baase, E. G.
Affiliations
  • University at Buffalo, State University of New York (US)
  • Department of Exercise and Nutrition Sciences, School of Public Health and Health Professions, University at Buffalo, Buffalo, New York, USA
Venue
Journal of Endocrinology
Published
2024-04-17
Volume
262
Issue
1
ISSN
  • 0022-0795 (ISSN-L)
  • 1479-6805
OpenAlex
W4394877548
Cited by
38
References
141
Citations by year
2026: 15 · 2025: 19 · 2024: 4
FWCI
3.38
Type
journal article
Language
en
Open access
Locations
  • Journal of Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases (K01DK120778, R01DK128030)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Eating Disorders and Behaviors
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
Keywords
glucagon-like peptide-1, binge eating, binge eating disorder, bulimia nervosa, GLP-1 receptor agonists, GLP-1 signaling, energy balance, food intake regulation, food reward
MeSH terms
Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor Agonists, Animals, Bulimia, Energy Intake, Energy Metabolism, Humans, Glucagon-Like Peptide 1, Binge-Eating Disorder

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The emerging role of glucagon-like peptide 1 in binge eating. https://app.cochat.ai/papers/10.1530/joe-23-0405
The paper
Balantekin, K. N., Kretz, M. J., & Mietlicki-Baase, E. G. (2024). The emerging role of glucagon-like peptide 1 in binge eating. Journal of Endocrinology. https://doi.org/10.1530/joe-23-0405

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.